Human Longevity Stock

Healthcare technology for genomic sciences.

Buy

Buy Human Longevity shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Human Longevity shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Human Longevity is on a mission to discover and harness the technological and biological unlocks that amplify span of life, health, and high-performance. HLI’s mission is to identify the therapeutically targetable mechanisms responsible for age-related human biological decline and to apply this intelligence to develop innovative solutions to interrupt or block those processes, meaningfully extending the human lifespan.

Sector

Healthcare & Life Sciences

Founded

2013

Headquarters

San Diego, CA

Human Longevity Funding

Human Longevity Funding History

Sign up to gain insights into Human Longevity funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series B Aug 21, 2024 21M
XXXXX
XXXXX
Series B Apr 25, 2023 11M
XXXXX
XXXXX
Series A Jun 18, 2019 20M
XXXXX
XXXXX
Series B Feb 16, 2017 203M
XXXXX
XXXXX
Series B Mar 26, 2015 320M
XXXXX
XXXXX
Series A Mar 20, 2014 80M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Human Longevity shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Human Longevity shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Human Longevity Management Team

Human Longevity people and management

  • Board Member
    Brett Blundy
  • Board Member
    Wei-Wu He
  • Board Member
    Alan B. Colowick
  • Board Member
    Maky Zanganeh
  • Board Member
    Robert Hariri
  • Board Member
    Robert Duggan
  • Co-Founder, Board Member
    Peter Diamandis
  • Chief Innovation Officer, President
    David Karow
  • Chief Privacy Officer
    Mert Gambito
  • Chief Medical Officer, Updated
    Julie Chen
  • CTO
    Wei Zhou
  • Co-Founder
    J. Craig Venter
  • Chief Commercial Officer
    James Dickey
  • Chief Administrative Officer
    James Hu

Investors

Major Human Longevity investors

  • Faridan Ventures

  • Illumina

  • GE Ventures

  • BB Retail Capital

  • Draper Fisher Jurvetson (DFJ)

  • Emerging Technology Partners

  • Celgene Corp

  • Genting Berhad

  • OS Fund

  • TVM Capital

  • Panacea Venture

Human Longevity Valuations & Financials

Gain Insights Into Human Longevity Stock Valuation & Share Prices

View real-time NPM data on Human Longevity stock including daily Human Longevity stock price estimates, valuation history, and historical share price information. Access Human Longevity financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Human Longevity pricing across six independent market signals. Looking for private company due diligence data sources on Human Longevity? Get in touch to learn more.

Similar Companies

Explore companies

like Human Longevity

  • Curology-Logo

    Curology

    Healthcare & Life Sciences

    Offers personalized prescription skin care medications delivered directly to you.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Devoted Health

    Healthcare & Life Sciences

    Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

  • Roman Health Ventures-Logo

    Ro

    Healthcare & Life Sciences

    Healthcare technology for a patient-centric healthcare system.

  • Spring Health-Logo

    Spring Health

    Healthcare & Life Sciences

    Mental healthcare solutions for employers and health plans.

  • Transcarent-Logo

    Transcarent

    Healthcare & Life Sciences

    Automates procurement, invoicing, and payments to streamline supply chain operations.

  • Everlywell-Logo

    Everly Health

    Healthcare & Life Sciences

    Offers health and wellness kits for at-home sample collection and processing at certified labs.

FAQ

Questions?

We have answers

Buy Human Longevity Stock

Human Longevity stock does not trade on public stock exchanges. Human Longevity stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Human Longevity stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Human Longevity Stock

Human Longevity Stock does not trade on public stock exchanges. In order to sell Human Longevity shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Human Longevity Stock Price

Human Longevity does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Human Longevity share price and other valuable private market data.

Read more about secondary market private company stock prices:

Human Longevity Stock Ticker Symbol

There is no ticker symbol for Human Longevity stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Human Longevity Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Human Longevity stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Human Longevity Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Human Longevity stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Human Longevity Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Human Longevity IPO

Human Longevity is a private company and has not had an IPO. There is currently no Human Longevity IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Human Longevity IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.